HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS:SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an overview of the Company’s business strategy will be given at the 30th Annual J. P. Morgan Healthcare Conference, being held at the Westin St. Francis Hotel in San Francisco, California. The Spectrum Pharmaceuticals presentation is at 11 am Pacific Time on Thursday, January 12, 2012 in the California East room.
